0001144204-18-013455.txt : 20180307 0001144204-18-013455.hdr.sgml : 20180307 20180307214630 ACCESSION NUMBER: 0001144204-18-013455 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180305 FILED AS OF DATE: 20180307 DATE AS OF CHANGE: 20180307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BFI Co., LLC CENTRAL INDEX KEY: 0001601607 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 18674892 BUSINESS ADDRESS: STREET 1: 300 FRANK W. BURR BLVD., STE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 2013297300 MAIL ADDRESS: STREET 1: 300 FRANK W. BURR BLVD., STE 21 CITY: TEANECK STATE: NJ ZIP: 07666 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 4 1 tv487754_form4.xml FORM 4 X0306 4 2018-03-05 0 0001069899 PHIBRO ANIMAL HEALTH CORP PAHC 0001601607 BFI Co., LLC 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666 0 0 1 0 Class A Common Stock 2018-03-05 4 C 0 36000 0 A 72000 D Class A Common Stock 2018-03-05 4 S 0 5134 38.97 D 66866 D Class A Common Stock 2018-03-05 4 S 0 6866 39.64 D 60000 D Class A Common Stock 2018-03-06 4 S 0 10600 38.69 D 49400 D Class A Common Stock 2018-03-06 4 S 0 1400 39.18 D 48000 D Class A Common Stock 2018-03-07 4 S 0 12000 38.92 D 36000 D Class B Common Stock 0 2018-03-05 4 C 0 36000 0 D Class A Common Stock 36000 20516034 D Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, and has no expiration date. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.40 to $39.35, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.40 to $40.13, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $39.00, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.05 to $39.55, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.45 to $39.45, inclusive. /s/ Thomas G. Dagger, as Attorney-in-Fact for BFI Co., LLC 2018-03-07